Primary Site >> Pancreatic Cancer
Gene >> PTPRF
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. PMID: 9825482 |
Ref: Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma. PMID: 11154172 |
Ref: [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog]. PMID: 12434103 |
Ref: Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer. PMID: 17357189 |
Ref: Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2. PMID: 16479142 |
Ref: Medical treatment of benign insulinoma using octreotide LAR: a case report. PMID: 17124362 |
Ref: Rheumatoid arthritis associated with the use of Sandostatin(R) LAR(R) depot in a patient with pancreatic neuroendocrine tumor. An association or a coincidence? The first case report. PMID: 21737909 |
Ref: Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. PMID: 23102680 |
Ref: Elderly patients with pancreatic cancer. PMID: 25076333 Ref: Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors. PMID: 25688512 |
Ref: Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs. PMID: 25689143 Ref: Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer. PMID: 26126727 |
Ref: [Treatment Strategy for Non-Functional Pancreatic Neuroendocrine Tumors (P-NETs) at Kurume University Hospital]. PMID: 26809536 |
Ref: 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer. PMID: 29590448 Ref: Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapy. PMID: 29848124 Ref: Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors. PMID: 30057604 |